Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Serostim [somatropin (rDNA origin) for injection] Jan 2001

Serono, Inc. issued a warning upon discovery of counterfeit versions of Serostim, a drug used to treat AIDS wasting. The counterfeit product is of unknown safety and efficacy and may pose a health risk to patients. The counterfeit product has been packaged to appear as a drug product with lot numbers MNK612A and MNH605A and is readily distinguishable from authentic Serostim by features specified in the manufacturers press release.

[May 17, 2001 - Letter - Serono, Inc.]
[May 17, 2001 - Press Release - Serono, Inc.]
[January 23, 2001 - Press Release - Serono, Inc.]

-
-